Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Metformin and Megestrol in Treatment of Endometrial Hyperplasia
IRCT20221101056361N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin and megestrol in endometrial hyperplasia (EH), sponsored by Shahrekord University of Medical Sciences. Started Mar 2022; status: completed.
02
Drugs
metforminmegestrol
03
Conditions
endometrial hyperplasia (EH)
Beyond the preview
Go deeper on IRCT20221101056361N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221101056361N1.